Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
2023 · Intensive Care Medicine · 233 citations
https://doi.org/10.1007/s00134-022-06944-2
H
Hideaki Kato
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
349
Papers
8.7K
Citations
42
h-index
115
i10-index
Hideaki Kato is an academic researcher from Shizuoka University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Hepatitis C virus research. The author has an h-index of 42, co-authored 297 publications.
ORCID: 0000-0002-7853-5721Papers by this author
worksHepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans
2013 · PLoS ONE · 202 citations
https://doi.org/10.1371/journal.pone.0082163
Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study
2019 · Anaerobe · 65 citations
https://doi.org/10.1016/j.anaerobe.2019.03.007
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023 · JAMA · 45 citations
https://doi.org/10.1001/jama.2023.21407
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination
2022 · Vaccine · 37 citations
https://doi.org/10.1016/j.vaccine.2022.03.057
Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan
2022 · Journal of Global Antimicrobial Resistance · 34 citations
https://doi.org/10.1016/j.jgar.2022.04.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat